Current implications of cyclophilins in human cancers

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Lee, Jinhwa ^a   Kim, Sung Soo ^b  

^a Dongseo University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CYCLOPHILIN; CYCLOPHILIN 40; CYCLOPHILIN A; CYCLOPHILIN B; CYCLOPHILIN C; CYCLOPHILIN D; PEPTIDYLPROLYL ISOMERASE; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; GENE EXPRESSION REGULATION; HUMAN; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION; METABOLISM; NEOPLASM; PATHOLOGY;

CYCLOPHILINS; HUMANS; NEOPLASMS;

EID: 77954687787     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-97     Document Type: Review

References (56)

1. The mode of action of peptidyl prolyl cis/trans isomerase in vivo: Binding vs catalysis. G Fischer T Tradler T Zarnt, FEBS Lett 1998 426 17 20 10.1016/S0014-5793(98)00242-7 9598969
2. Protein folding. Prolyl isomerase join the fold. FX Schmid, Curr Biol 1995 5 993 994 10.1016/S0960-9822(95)00197-7 8542292
3. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. SL Schreiber, Cell 1992 70 365 368 10.1016/0092-8674(92)90158-9 1379518
4. Peptidyl-prolyl cis-trans isomerase, a superfamily of ubiquitous folding catalysts. SF Göthel MA Marahiel, Cell Mol Life Sci 1999 55 423 436 10.1007/s000180050299 10228556
5. Prolyl isomerase and nuclear function. T Hunter, Cell 1998 92 141 143 10.1016/S0092-8674(00)80906-X 9458036
6. Protein folding and the regulation of signaling pathways. SL Rutherford CS Zuker, Cell 1994 79 1129 1132 10.1016/0092-8674(94)90003-5 8001149
7. Calcineurin is a common target of cyclophilin-cyclosporine A and FKBP-FK506 complexes. J Liu JD Farmer Jr WS Lane J Friedman I Weissman SL Schreiber, Cell 1991 66 807 815 10.1016/0092-8674(91)90124-H 1715244
8. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity targets functions. A Galat, Curr Top Med Chem 2003 3 1315 1347 10.2174/1568026033451862 12871165
9. A cyclophilin-related protein involved in the function of natural killer cells. SK Anderson S Gallinger J Roder J Frey HA Young JR Ortaldo, Proc Natl Acad Sci USA 1993 90 542 546 10.1073/pnas.90.2.542 8421688
10. Cyclophilin A modelates the sensitivity of HIV-1 to host restriction factors. GJ Towers T Hatziioannou S Cowan SP Goff J Luban PD Bieniasz, Nat Med 2003 9 1138 1143 10.1038/nm910 12897779
11. Natural products as promising drug candidates for the treatment of hepatitis B and C. C Wohlfarth T Efferth, Acta Pharmacol Sin 2009 30 1 25 30 10.1038/aps.2008.5 19060918
12. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin a. K Satoh P Nigro BC Berk, Antioxid Redox Signal 2010 1:12 5 675 682 10.1089/ars.2009.2875
13. Cyclosporine A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporine A-induced cytotoxicity. F Hong J Lee JW Song SJ Lee H Ahn JJ Cho J Ha SS Kim, FASEB J 2002 16 1633 1635 12207006
14. The mechanism of action of FK- 506 and cyclosporine A. G Wiederrecht E Lam S Hung M Martin N Sigal, Ann NY Acad Sci 1993 696 9 19 10.1111/j.1749-6632. 1993.tb17137.x 7509138
15. Cloning genes responsive to a hepatocarcinogenic peroxisome proliferator chemical reveals novel targets of regulation. JC Corton ES Moreno A Merritt C Bocos RC Cattley, Cancer Lett 1998 134 61 71 10.1016/S0304-3835(98)00241-9 10381131
16. Proteome analysis of hepatocellular carcinoma. SO Lim SJ Park W Kim SG Park HJ Kim YI Kim TS Sohn JH Noh G Jung, Biochem Biophys Res Commun 2002 291 1031 1037 10.1006/bbrc.2002.6547 11866469
17. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. BA Howard Z Zheng MJ Campa MZ Wang A Sharma E Haura JE Herndon MC Fitzgerald G Bepler EF Patz Jr, Lung Cancer 2004 46 313 323 10.1016/j.lungcan.2004.05.013 15541816
18. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. BA Howard R Furumai MJ Campa ZN Rabbani Z Vujaskovic XF Wang EF Patz Jr, Cancer Res 2005 65 8853 8860 10.1158/0008-5472.CAN-05-1219 16204056
19. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. H Yang J Chen J Yang S Qiao S Zhao L Yu, Biochem Biophys Res Commun 2007 361 763 767 10.1016/j.bbrc.2007.07.085 17678621
20. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. MJ Campa MZ Wang B Howard MC Fitzgerald EF Patz Jr, Cancer Res 2003 63 1652 1656 12670919
21. Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine. D Cecconi H Astner M Donadelli M Palmieri E Missiaglia M Hamdan A Scarpa PG Righetti, Electrophoresis 2003 24 4291 4303 10.1002/elps.200305724 14679576 (Pubitemid 38094474)
22. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. J Shen MD Person J Zhu JL Abbruzzese D Li, Cancer Res 2004 64 9018 9026 10.1158/0008-5472.CAN-04- 3262 15604267
23. Effect of cyclophilin A on gene expression in human pancreatic cancer cells. M Li H Wang F Li WE Fisher C Chen Q Yao, Am J Surg 2005 190 739 745 10.1016/j.amjsurg.2005.07.013 16226951 (Pubitemid 41446498)
24. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. M Li Q Zhai U Bharadwaj H Wang F Li WE Fisher C Chen Q Yao, Cancer 2006 106 2284 2294 10.1002/cncr.21862 16604531
25. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. K Mikuriya Y Kuramitsu S Ryozawa M Fujimoto S Mori M Oka K Hamano K Okita I Sakaida K Nakamura, Int J Oncol 2007 30 849 855 17332923
26. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. J Zheng JE Koblinski LV Dutson YB Feeney CV Clevenger, Cancer Res 2008 68 7769 7778 10.1158/0008-5472.CAN-08-0639 18829531
27. Differential protein expression in the cytosol fraction of an MCF-7 breast cancer cell line selected for resistance toward melphalan. Y Hathout K Riordan M Gehrmann C Fenselau, J Proteome Res 2002 1 435 442 10.1021/pr020006i 12645915
28. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry. C Melle D Osterloh G Ernst B Schimmel A Bleul F von Eggeling, Int J Mol Med 2005 16 11 17 15942672
29. Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells. J Lou N Fatima Z Xiao S Stauffer G Smythers P Greenwald IU Ali, Cancer Epidemiol Biomarkers Prev 2006 15 1598 1606 10.1158/1055-9965.EPI-06-0216 16985019
30. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. CS Wong VW Wong CM Chan BB Ma EP Hui MC Wong MY Lam TC Au WH Chan W Cheuk AT Chan, Oncol Rep 2008 20 89 98 18575723
31. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. J Chen QY He AP Yuen JF Chiu, Proteomics 2004 24 2465 2475 10.1002/pmic.200300762 (Pubitemid 39025347)
32. Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. YJ Qi QY He YF Ma YW Du GC Liu YJ Li GS Tsao SM Ngai JF Chiu, J Cell Biochem 2008 104 1625 1635 10.1002/jcb.21727 18320592
33. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines. M Al-Ghoul TB Brück JL Lauer-Fields VS Asirvatham C Zapata RG Kerr GB Fields, J Proteome Res 2008 27 4107 4118 10.1021/pr800174k
34. Cyclosproin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells. X Han SH Yoon Y Ding TG Choi WJ Choi YH Kim YJ Kim YB Huh J Ha SS Kim, Oncol Rep 2010 23 1053 1062 10.3892/or-00000816 20204291
35. Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: Tissue- and treatment-specificity. G Weisinger M Gavish C Mazurika O Zinder, Biochimica et Biophysica Acta - Gene Structure and Expression 1999 1446 3 225 232 10.1016/S0167-4781(99)00091-3 (Pubitemid 29401895)
36. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. KJ Choi YJ Piao MJ Lim JH Kim J Ha W Choe SS Kim, Cancer Res 2007 67 3654 3662 10.1158/0008-5472.CAN-06-1759 17440077
37. Global investigation of p53-induced apoptosis through quantitative proteomic profiling using comparative amino acid-coded tagging. S Gu Z Liu S Pan Z Jiang H Lu O Amit EM Bradbury A Hu C X Chen, Mol Cell Proteomics 2004 3 998 1008 10.1074/mcp.M400033-MCP200 15284338
38. The regulation of exosome secretion: a novel function of the p53 protein. X Yu SL Harris AJ Levine, Cancer Res 2006 66 4795 4801 10.1158/0008-5472.CAN- 05-4579 16651434
39. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. F Mantovani F Tocco J Girardini P Smith M Gasco X Lu T Crook G Del Sal, Nat Struct Mol Biol 2007 14 912 920 10.1038/nsmb1306 17906639
40. Monitoring mouse prostate development by profiling and imaging mass spectrometry. P Chaurand MA Rahman T Hunt JA Mobley G Gu JC Latham RM Caprioli S Kasper, Molecular & Cellular Proteomics 2008 7 411 423
41. The human tumor cell derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. C Biswas Y Zhang R DeCastro H Guo T Nakamura H Kataoka K Nabeshima, Cancer Res 1995 55 434 439 7812975
42. Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. V Yurchenko T Pushkarsky JH Li WW Dai B Sherry M Bukrinsky, J Biol Chem 2005 280 17013 17019 10.1074/jbc.M412851200 15671024
43. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. S Boulos BP Meloni PG Arthur B Majda C Bojarski NW Knuckey, Neurobiol Dis 2006 25 54 64 10.1016/j.nbd.2006.08.012 17011206
44. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. J Zheng JE Koblinski LV Dutson YB Feeney CV Clevenger, Cancer Res 2008 68 7769 7778 10.1158/0008-5472.CAN-08-0639 18829531
45. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Kim TG Choi Y Ding Y Kim KS Ha KH Lee I Kang J Ha RJ Kaufman J Lee W Choe SS Kim, J Cell Sci 2008 121 3636 364 10.1242/jcs.028654 18946027
46. Expression of cyclophilin B is associated progression and regulation with malignant of genes implicated in pathogenesis of breast cancer. F Fang AJ Flegler P Du S Lin CV Clevenger, Am J Pathol 2009 174 1 297 308 10.2353/ajpath.2009.080753 19056847
47. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumorspecific CTLs. S Gomi M Nakao F Niiya Y Imamura K Kawano S Nishizaka A Hayashi Y Sobao K Oizumi K Itoh, J Immunol 1999 163 4994 5004 10528204
48. Thrombin-cleaved COOH-terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Z Mi T Oliver H Guo C Gao PC Kuo, Cancer Res 2007 67 4088 4097 10.1158/0008-5472.CAN-06-4066 17483319
49. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2- related proteins. I Marzo C Brenner N Zamzami SA Susin G Beutner D Brdiczka R Rémy ZH Xie JC Reed G Kroemer, J Exp Med 1998 187 1261 1271 10.1084/jem.187.8.1261 9547337
50. Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. DT Lin JD Lechleiter, J Biol Chem 2002 277 31134 31141 10.1074/jbc.M112035200 12077116
51. Biochemistry: A pore way to die. A Halestrap, Nature 2005 434 578 579 10.1038/434578a 15800609
52. Involvement of cyclophilin D in the activation of a mitochondrial pore by Ca2+ and oxidant stress. A Tanveer S Virji L Andreeva NF Totty JJ Hsuan JM Ward M Crompton, Eur Biochem J 1996 238 166 172 10.1111/j.1432-1033.1996.0166q.x
53. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. RA Eliseev J Malecki T Lester Y Zhang J Humphrey TE Gunter, J Biol Chem 2009 284 9692 9699 10.1074/jbc.M808750200 19228691
54. Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. BK Ward PJ Mark DM Ingram RF Minchin T Ratajczak, Breast Cancer Res Treat 1999 58 267 280 10.1023/A:1006390804515 10718488
55. Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock. PJ Mark BK Ward P Kumar H Lahooti RF Minchin T Ratajczak, Cell Stress Chaperones 2001 6 59 70 10.1379/1466-1268(2001)006<0059:HCIAHS>2.0.CO;2 11525244
56. Allelic loss of cyclophilin 40, an estrogen receptor-associated immunophilin, in breast carcinomas. BK Ward P Kumar GR Turbett JE Edmondston JM Papadimitriou NG Laing DM Ingram RF Minchin T Ratajczak, J Cancer Res Clin Oncol 2001 127 109 115 10.1007/s004320000182 11216911